Antibiotice Iasi has inaugurated a 2.5 MW photovoltaic facility, a project funded by the Romanian Recovery and Resilience Plan (RRP).
Antibiotice Iași Company, a pharmaceutical manufacturer with Romanian capital, became a member of the Sustainable Romania Coalition, the first platform for sustainable development established by the Embassy of Sustainability in Romania (ASR).
The state-owned drug manufacturer Antibiotice Iași made total investments worth RON 27.17 million (€5.4 million) in the first six months of the year for sustainable development.
Antibiotice Iaşi Company, the largest Romanian producer of generic drugs, will build a 2.5 MW photovoltaic plant. The company announced that it obtained from the Ministry of Investments and European Projects financing of RON4.08 million (€816,000) in this regard.
SPIE Energy Poland announced new projects at a time of major investment in Poland to support the energy transition.
ABB's Smart Buildings Division has announced a strategic collaboration with the World Green Building Council's (WorldGBC) European Regional Network (ERN) to accelerate sustainable and energy-efficient building practices across Europe.
Poland has received €9.4 billion from the EU's National Recovery Plan (NRP) after fulfilling its second and third payment requests.
SolarPower Europe (SPE) forecasts 65.5GW of solar PV additions in the EU for 2024, marking a significant slowdown compared to previous years.
EIB will provide €243 million in financing to leading independent clean wind and solar energy operator ERG Group to promote the development of renewable energy in Italy, France and Germany.
